Ausgabe 3/2016
Inhalt (9 Artikel)
Hepatotoxicity Associated with the Use of Anti-TNF-α Agents
Joshua B. French, Maurizio Bonacini, Marwan Ghabril, David Foureau, Herbert L. Bonkovsky
Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review
Rose I. Okonkwo, Anita E. Weidmann, Emmanuel E. Effa
Post-Marketing Benefit–Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis
Edouard Ledent, Alfons Lieftucht, Hubert Buyse, Keiji Sugiyama, Michael Mckenna, Katsiaryna Holl
Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter
Abeed Sarker, Karen O’Connor, Rachel Ginn, Matthew Scotch, Karen Smith, Dan Malone, Graciela Gonzalez
Clinicians’ Reports in Electronic Health Records Versus Patients’ Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin
Maxim Topaz, Kenneth Lai, Neil Dhopeshwarkar, Diane L. Seger, Roee Sa’adon, Foster Goss, Ronen Rozenblum, Li Zhou
A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases
Mickael Arnaud, Francesco Salvo, Ismaïl Ahmed, Philip Robinson, Nicholas Moore, Bernard Bégaud, Pascale Tubert-Bitter, Antoine Pariente
Use of Prescription Drug Samples in the USA: A Descriptive Study with Considerations for Pharmacoepidemiology
Christian Hampp, Patty Greene, Simone P. Pinheiro
The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015
Roni P. Dodiuk-Gad, Cristina Olteanu, Wen-Hung Chung, Neil H. Shear